ALBO - Mirum: Rare Disease Play With Upcoming Catalysts May, 18 2021 08:00 AM Albireo Pharma Inc. Mirum has two assets targeting rare liver diseases. Lead asset has a PDUFA in September. Current lows make MIRM interesting. For further details see: Mirum: Rare Disease Play With Upcoming Catalysts